Methods of Treating Age-Related Macular Degeneration Read more about Methods of Treating Age-Related Macular Degeneration US Application 61/429,580Filed on 2011-01-04
Methods of Using Sterculic Acid Read more about Methods of Using Sterculic Acid US Application 61/358,485Filed on 2010-06-25
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Cosmetic Tanning Read more about Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Cosmetic Tanning US Application 61/308,771Filed on 2010-02-26
Systemic Immunosuppression in the Treatment of Age-Related Macular Degeneration and Diabetic Retinopathy Read more about Systemic Immunosuppression in the Treatment of Age-Related Macular Degeneration and Diabetic Retinopathy US Application 61/254,439Filed on 2009-10-23
METHODS FOR USING INTERFERON GAMMA TO ABSORB FLUID FROM THE SUBRETINAL SPACE Read more about METHODS FOR USING INTERFERON GAMMA TO ABSORB FLUID FROM THE SUBRETINAL SPACE US Application 61/089,157Filed on 2008-08-15
Use Of Retinal Pigment Epithelia-enriched MicroRNAs To Prevent Cell-differentiation, Proliferation, And Migration In Neovascular Disease And Tumor Development Read more about Use Of Retinal Pigment Epithelia-enriched MicroRNAs To Prevent Cell-differentiation, Proliferation, And Migration In Neovascular Disease And Tumor Development US Application 61/092,102Filed on 2008-08-27
Methods for Treatment of Degenerative Disease Associated with Apoptosis Read more about Methods for Treatment of Degenerative Disease Associated with Apoptosis US Application 60/972,780Filed on 2007-09-15
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE Read more about USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE US Application 60/837,312Filed on 2006-08-11
Use of IL-23 or IL-23R Antagonists to Treat Uveitis Read more about Use of IL-23 or IL-23R Antagonists to Treat Uveitis US Application 60/713,792Filed on 2005-09-01
The Use Of High Dose Anti-IL2 Receptor Antibody To Treat Acutely Active Sight Threatening Non Infectious Uveitis Read more about The Use Of High Dose Anti-IL2 Receptor Antibody To Treat Acutely Active Sight Threatening Non Infectious Uveitis US Application 60/616,760Filed on 2004-10-06